Dual roles of Makorin ring finger protein 1 in ubiquitination and RNA biology: regulatory mechanisms and therapeutic implications in human diseases
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2025.117441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Jia-Le Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Lishui Service Platform for Technological Innovations in Traditional Chinese Medicine Industry, Lishui University, Lishui 323000, China. Hauptthemen laut MEDLINE: Jumonji Domain-Containing Histone Demethylases, Metabolic Diseases, Neoplasms, Nerve Tissue Proteins. Die Arbeit nennt 132 Literaturangaben. Gefördert von: Natural Science Foundation of Ningbo Municipality, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ubiquitination dynamically regulates protein stability and signaling networks through post-translational modifications. Makorin ring finger protein 1 (MKRN1) is a unique member of the MKRN family that functions as E3 ubiquitin ligase and RNA-binding protein. It maintains cellular homeostasis via a dual regulatory mechanism involving ubiquitination and RNA biology. This review summarizes the regulatory mechanisms of MKRN1 in core pathways, such as p53-p21, Wnt/β-catenin, transforming growth factor beta, phosphatidylinositol 3 kinase/protein kinase, nuclear factor kappa B, and various pathological states, including metabolic disorders, tuberculosis, and cancer. We critically evaluated its structural architecture, disease-related functions, and pharmacological potential of MKRN1. We highlight that therapeutic targeting strategies, such as indirect inhibitors of KDM7A, discuss challenges in the development of direct MKRN1-targeting drugs, and propose that elucidating the interaction between MKRN1 in the ubiquitin-proteasome system and RNA regulatory system may open new avenues for the treatment of human diseases. Overall, MKRN1 exhibits complex, context-dependent roles across various diseases, making it a challenging yet compelling therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Lishui Service Platform for Technological Innovations in Traditional Chinese Medicine Industry, Lishui University, Lishui 323000, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Educatio…
- Zhejiang Lishui Service Platform for Technological Innovations in Traditional Chinese Medicine Industry, Lishui University, Lishui 323000, China. Electronic address: jchen@lsu.edu.cn.
- State Key Laboratory for Quality and Safety of Agro-products, School of Marine Sciences, Ningbo University, Ningbo 315211 Zhejiang, China. Electronic address: champion2014@163.com.
Förderung
- Natural Science Foundation of Ningbo Municipality
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- Zhejiang Provincial Xinmiao Talents Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, J. L., Wang, Z. X., Chen, J., Zhong, H. J., & Yang, G. J. (2026). Dual roles of Makorin ring finger protein 1 in ubiquitination and RNA biology: regulatory mechanisms and therapeutic implications in human diseases. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117441
Vancouver
Wu JL, Wang ZX, Chen J, Zhong HJ, Yang GJ. Dual roles of Makorin ring finger protein 1 in ubiquitination and RNA biology: regulatory mechanisms and therapeutic implications in human diseases. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117441
BibTeX
@article{Wu2026,
author = {Wu, Jia-Le and Wang, Zi-Xuan and Chen, Jie and Zhong, Hai-Jing and Yang, Guan-Jun},
title = {Dual roles of Makorin ring finger protein 1 in ubiquitination and RNA biology: regulatory mechanisms and therapeutic implications in human diseases},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2025.117441}
}
EUVIMED